A pivotal year for NAFLD and NASH therapeutics

被引：0
|
作者：
Jean-François Dufour
机构：
[1] Center for Digestive Diseases Lausanne,
来源：
Nature Reviews Endocrinology | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The metabolic dysfunction that characterizes obesity and type 2 diabetes mellitus affects not only the heart and kidneys, but also the liver. Although lifestyle modification remains the cornerstone in the management of metabolic liver diseases, the field has progressed this year, with a new definition, validation of non-invasive biomarkers and numerous clinical trials.
引用
收藏
页码：75 / 76
页数：1
相关论文
共 50 条
  • [1] A pivotal year for NAFLD and NASH therapeutics
    Dufour, Jean-Francois
    NATURE REVIEWS ENDOCRINOLOGY, 2024, 20 (02) : 75 - 76
  • [2] Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
    Finan, Brian
    Parlee, Sebastian D.
    Yang, Bin
    MOLECULAR METABOLISM, 2021, 46
  • [3] Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression
    Miyao, Masashi
    Kotani, Hirokazu
    Ishida, Tokiko
    Kawai, Chihiro
    Manabe, Sho
    Abiru, Hitoshi
    Tamaki, Keiji
    LABORATORY INVESTIGATION, 2015, 95 (10) : 1130 - 1144
  • [4] NAFLD/NASH
    Bugianesi, Elisabetta
    Petta, Salvatore
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 549 - 550
  • [5] Melanin produced by yeast Pseudonadsoniella brunnea as novel therapeutics agents in NAFLD/NASH management
    Chyzhanska, Y.
    Falalyeyeva, T.
    Kobyliak, N.
    Chyzhanska, N.
    Beregova, T.
    Ostapchenko, L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 90 - 90
  • [6] NAFLD/NASH and Diabetes
    Garg, Kavita
    Brackett, Scott
    Hirsch, Irl B.
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : S174 - S186
  • [7] NASH THERAPEUTICS
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 9 - 10
  • [8] NAFLD and NASH and Diabetes
    Garg, Kavita
    Reinicke, Trenton
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : S198 - S205
  • [9] NASH/NAFLD management
    James, OFW
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (04) : 200 - 203
  • [10] Nanoparticles in NAFLD therapeutics
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 414 - 414
12345